What is a Charcot‑Bouchard aneurysm?

Charcot-Bouchard Aneurysm

Charcot-Bouchard aneurysms are tiny, microaneurysms (typically <1.5 mm) that develop on small perforating arteries in the brain, particularly the lenticulostriate arteries supplying the basal ganglia, and are historically associated with chronic hypertension and cerebral small vessel disease. 1, 2

Anatomic and Pathologic Characteristics

Location and Size:

• These microaneurysms arise from small perforating arteries, most commonly the lenticulostriate arteries in the basal ganglia region 2, 3
• The parent vessel diameter typically ranges from 0.26-0.37 mm, with the aneurysm itself measuring 0.73-1.39 mm in maximum diameter 2
• They can also occur in other deep brain structures supplied by small perforating vessels 4

Morphology:

• Appear as focal dilations on tiny penetrating arteries with attenuated vessel walls 1
• Demonstrate saccular or fusiform configurations on high-resolution imaging 2, 3
• Histologically represent one of the cerebral amyloid angiopathy (CAA)-associated microangiopathies, along with fibrinoid necrosis and vessel fibrosis 4

Associated Conditions and Risk Factors

Primary Associations:

• Chronic arterial hypertension is the most strongly associated risk factor 1, 4
• Cerebral amyloid angiopathy (CAA) is another major association, with Charcot-Bouchard aneurysms representing one of the CAA-associated microangiopathies 4
• Severe cerebral small vessel disease, including both hypertensive arteriopathy and CAA 4

Patient Demographics:

• Predominantly found in elderly individuals with multiple cerebrovascular comorbidities 4
• Can occur in younger patients without hypertension, particularly when associated with basal ganglia hemorrhage 3, 5

Clinical Significance and Controversy

Historical Context:

• First described by Jean-Martin Charcot and Charles Jacques Bouchard in 1866 as the source of hypertensive intracerebral hemorrhage 6
• Their actual prevalence and significance in causing intracerebral hemorrhage (ICH) has been controversial for over a century 7

Current Understanding:

• Modern pathologic studies using advanced techniques (alkaline phosphatase endothelial staining and high-resolution microradiography) suggest these aneurysms are actually quite rare 7
• In autopsy series of over 2,700 cases, Charcot-Bouchard aneurysms were found in only 12 patients, and only one had a large ICH 4
• They may represent a manifestation of severe cerebral small vessel disease rather than a primary cause of hemorrhage 4
• When present, they are more commonly associated with microhemorrhages or small infarcts in the vicinity rather than large hemorrhages 4

Diagnostic Approach

Imaging Modalities:

• 7T MRI provides the highest spatial resolution and can detect these microaneurysms in vivo, allowing differentiation from looped vessels that can mimic aneurysms on 2D imaging 2
• CT Angiography (CTA) can demonstrate these lesions, particularly in young patients with basal ganglia hemorrhage without hypertension 3
• MR Angiography (MRA) with contrast enhancement can identify these small aneurysms 3
• Catheter angiography remains confirmatory but may miss very small lesions due to their distal location and tiny size 3, 5

Clinical Scenarios Warranting Investigation:

• Young patients experiencing basal ganglia hemorrhage without arterial hypertension 3
• Presence of associated subarachnoid hemorrhage component 3
• Intraparenchymal hemorrhage in otherwise healthy patients without typical risk factors 5

Treatment Considerations

Surgical Management:

• When identified as the source of hemorrhage, microsurgical clipping can be performed using stereotactic guidance 5
• The aneurysm base often involves the parent vessel wall, requiring wrapping with cotton and reinforcement with cyanoacrylate glue rather than simple clipping 5
• Delayed surgical intervention after initial stabilization may be appropriate 5

Important Caveats:

• Most intracerebral hemorrhages attributed to these aneurysms are likely multifactorial, involving hypertensive arteriopathy, CAA, and other small vessel disease processes 4
• The rarity of these lesions means aggressive vascular investigation is warranted primarily in young patients with unexplained basal ganglia hemorrhage 5
• Injection artifacts and misinterpretation of arteriolar coils can lead to false-positive diagnoses, emphasizing the need for advanced imaging techniques 7